Inventor · disambiguated record
Brad M. Savall
Also filed as: SAVALL BRAD · SAVALL BRAD M
32 granted patents·8 pending applications·166 citations·filing 2004–2023
97Inventor score
Files withJANSSEN PHARMACEUTICA NV29BRANSTETTER BRYAN JAMES2BUTLER CHRISTOPHER R1CAI HUI1CHAI WENYING1
Top patents by PatentIndex Score
40 records- 0196US9464084B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·16 cites·6 claims
- 0295US9066946B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·20 cites·32 claims
- 0394US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0494US10150765B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 11, 2018·11 cites·18 claims
- 0592US11820770B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 21, 2023·1 cites·20 claims
- 0692US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 0792US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 0891US10112937B2P2X7 modulators and methods of useJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 30, 2018·11 cites·40 claims
- 0990US12247027B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Mar 11, 2025·0 cites·10 claims
- 1090US9586962B2Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulatorsLETAVIC MICHAEL A·Filed 2012·Granted Mar 7, 2017·12 cites·14 claims
- 1190US7923451B22-aminopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Apr 12, 2011·10 cites·5 claims
- 1288US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 1387US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 1486US11225478B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 18, 2022·1 cites·46 claims
- 1585USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 1685US9040534B2[1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 26, 2015·6 cites·20 claims
- 1784US8680275B2Fused heterocyclic compounds as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Mar 25, 2014·9 cites·20 claims
- 1884US7576092B2Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 18, 2009·6 cites·30 claims
- 1983US10703749B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 7, 2020·1 cites·6 claims
- 2082US8415366B22-aminopyrimidine modulators of the histamine H4 receptorEDWARDS JAMES P·Filed 2011·Granted Apr 9, 2013·4 cites·3 claims
- 2181US8841287B2Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptorCAI HUI·Filed 2009·Granted Sep 23, 2014·6 cites·31 claims
- 2276US7544698B2Indoles and benzoimidazoles as modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jun 9, 2009·2 cites·19 claims
- 2374US10100045B23-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 16, 2018·1 cites·16 claims
- 2473US8030321B2Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Oct 4, 2011·1 cites·14 claims
- 2572US9062044B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Jun 23, 2015·2 cites·18 claims
- 2671US10155769B2Fused azaheterocyclic compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 18, 2018·1 cites·26 claims
- 2771US10087185B2Fused bicylic pyridine compounds and their use as AMPA receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 2, 2018·1 cites·26 claims
- 2863US8716475B22-aminopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 6, 2014·0 cites·12 claims
- 2963US2017129901A1Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 3061US10053463B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 21, 2018·0 cites·33 claims
- 3161US8686142B22-aminopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·0 cites·1 claims
- 3259US9732087B2Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·0 cites·21 claims
- 3358US2015335651A1DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 3455US2011218338A12-aminopyrimidine modulators of the histamine h4 receptorJanseen Pharmaceutiacal NV·Filed 2011·Application pending·0 cites
- 3552US2005043378A1LTA4H modulatorsFiled 2004·Application pending·0 cites
- 3652US2005043379A1LTA4H ModulatorsFiled 2004·Application pending·0 cites
- 3751US10047092B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Aug 14, 2018·0 cites·11 claims
- 3851US2017298022A1Diamino-Pyridine, Pyrimidine, and Pyridazine Modulators of the Histamine H4 ReceptorJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 3944US2006223792A1Phenyl and pyridyl LTA4H modulatorsBUTLER CHRISTOPHER R·Filed 2006·Application pending·0 cites
- 4044US2022267277A1Dopamine receptor d1 agonists and methods of useSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →